Fluorescein sodium-guided surgery in glioblastoma multiforme: A prospective evaluation

British Journal of Neurosurgery

Volumn 22, Issue 1, 2008, Pages 99-103

  Koc, K ^a   Anik, I ^a   Cabuk, B ^a   Ceylan, S ^a  

^a KOCAELI UNIVERSITY   (Turkey)

Author keywords

Blood brain barrier; Fluorescein Na; Glioblastoma multiforme; Surgery

Indexed keywords

FLUORESCEIN SODIUM; LOMUSTINE; PROCARBAZINE; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION DOSE;

ADULT; AGED; BRAIN NEOPLASMS; CONTRAST MEDIA; FEMALE; FLUORESCEIN; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIOGRAPHY, INTERVENTIONAL; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 38549128796     PISSN: 02688697     EISSN: 1360046X     Source Type: Journal    
DOI: 10.1080/02688690701765524     Document Type: Article

References (15)

1. Walker AE, Robins M, Weinfeld FD. Epidemiology of brain tumours: the national survey of intracranial neoplasms. Neurology 1985;35:219-26.
2. Lacroix M, Abi-Said D, Fourney DR, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 2001;95:190-8.
3. Mineo JF, Bordron A, Baroncini M, et al. Prognosis factors of survival time in patients with glioblastoma multiforme: a multivariate analysis of 340 patients. Acta Neurochir (Wien) 2007;149(3):245-53.
4. Yuile P, Dent O, Cook R, Biggs M, Little N. Survival of glioblastoma patients related to presenting symptoms, brain site and treatment variables. J Clin Neurosci 2006;13:747-51.
5. Stark AM, Nabavi A, Mehdorn HM, Blfmer U. Glioblastoma multiforme report of 267 cases treated at a single institution. Surg Neurol 2005;63:162-9.
6. Albert FK, Forsting M, Sartor K, Adams HP, Kunze S. Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumour and its influence on regrowth and prognosis. Neurosurgery 1994;34:45-60.
7. Willems PWA, Taphoorn MJB, Burger H, Sprenkel VD, Tulleken CAF. Effectiveness of neuronavigation in resecting solitary intracerebral contrast-enhancing tumours: a randomized controlled trial. J Neurosurg 2006;104:360-8.
8. Schneider SW, Ludwig T, Tatenhorst L, et al. Glioblastoma cells release factors that disrupt blood-brain barrier features. Acta Neuropathol (Berl.) 2004;107:272-6.
9. Shinoda J, Yano H, Yoshimura S, Okumura A, Kaku Y, Sakai N. Fluorescence-guided resection of glioblastoma multiforme by using high-dose fluorescein sodium. Technical note. J Neurosurg 2003;99:597-603.
10. Stummer W, Novotny A, Step H, Goetz C, Bise K, Reule HJ. Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg 2000;93:1003-13.
11. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 2006;7(5):392-401.
12. Kuroiwa T, Kajimoto Y, Ohta T. Development of a fluorescein operative microscope for use during malignant glioma surgery. A technical note and preliminary report. Surg Neurol 1998;50:41-9.
13. Hammoud MA, Ligon BL, ElSouki R, Shi WM, Schomer DF, Sawaya R. Use of intraoperative ultrasound for localizing tumours and determining the extent of resection: a comparative study with magnetic resonance imaging. J Neurosurg 1996;84:737-41.
14. Litofsky NS, Bauer AM, Kasper RS, Sullivan CM, Dabbous OH. Image-guided resection of high-grade glioma: patient selection factors and outcome. Neurosurg Focus 2006;20(3):E16.
15. Knauth M, Wirtz CR, Tronnier VM, Aras N, Kunze S, Sartor K. Intraoperative MR Imaging increases the extent of tumour resection in patients with high-grade gliomas. AJNR Am J Neuroradiol 1999;20:1642-6.